A phase II investigator initiated trial of RS5614 for treatment of Cutaneous angiosarcoma
Latest Information Update: 22 Feb 2024
At a glance
- Drugs Paclitaxel (Primary) ; RS 5614 (Primary)
- Indications Haemangiosarcoma
- Focus Therapeutic Use
Most Recent Events
- 22 Feb 2024 According to a Renascience media release, this trial is ongoing at the Tohuku university.
- 22 Feb 2024 New trial record
- 01 Jan 2024 Study design published in the Experimental Dermatology.